Kit for detecting novel coronaviruses (2019-nCoV) based on double amplification technology and application of kit
A technology for 2019-ncov and coronavirus, applied in the detection/inspection of microorganisms, resistance to vector-borne diseases, biochemical equipment and methods, etc., can solve the problems of unfavorable popularization and application, and achieve the effect of improving detection efficiency and sensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0085] [Example 1] Sensitivity Test
[0086] Select a known concentration of the pseudovirus containing the 2019-nCoV target gene, perform a 10-fold concentration gradient dilution, and repeat each gradient dilution three times separately, and use the lowest dilution concentration with a 100% positive detection rate as the estimated detection limit , after the estimated detection limit is determined, dilute the 2019-nCoV pseudovirus to near the estimated detection limit concentration, and use the kit for detection, each concentration is tested 20 times to further accurately determine the minimum detection limit concentration (the positive rate is selected at The dilution above 95% is used as the detection limit sensitivity of this kit).
[0087] Table 1 2019-nCoV Pseudovirus Experiment Results - Determination of Estimated Detection Limit
[0088]
[0089] Table 2 Experimental results of 2019-nCoV pseudovirus - determination of detection limit
[0090]
[0091]
[00...
Embodiment 2
[0093] [Example 2] Specificity Verification
[0094] Other pathogens that are similar to the 2019 novel coronavirus species or cause similar symptoms (such as seasonal influenza A H1N1 virus, novel influenza A H1N1 (2009) virus, influenza A H3N2, H5N1, H7N9, influenza B Yamagata, influenza B Influenza type Victoria, RSV type A, RSV type B, parainfluenza type I, parainfluenza type II, parainfluenza type III, rhinovirus group A, B, C, adenovirus 1, 2, 3, 4, Types 5, 7, 55, enterovirus A, B, C, D, human metapneumovirus (human metapneumovirus), Epstein-Barr virus, measles virus, human cytomegalovirus, rotavirus, norovirus, Mumps virus, varicella-zoster virus, Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella, Bordetella pertussis, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Klebsiella pneumoniae, tuberculosis Mycobacterium, Aspergillus fumigatus, Candida albicans, Candida glabrata, Cryptococcus neoformans, coronavirus (HK...
Embodiment 3
[0099] [Example 3] Validation of clinical samples
[0100] 1, reagent of the present invention and reference reagent detection result analysis
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com